The landscape of surgical oncology is rapidly evolving with the advent of precision medicine, driven by breakthroughs in genomics and proteomics. This article explores how integrating molecular data is transforming surgical decision-making and enabling personalized treatment strategies. We examine emerging technologies such as next-generation sequencing, proteomic analysis, and molecular imaging, which provide critical insights into tumor biology and guide surgical interventions. The article also highlights the application of genomic and proteomic data in preoperative planning and the development of personalized resection strategies. Additionally, we will address the current challenges and future opportunities in this rapidly evolving field, emphasizing the need for continuous education, interdisciplinary collaboration, and ongoing research to fully realize the potential of precision medicine in thoracic surgical oncology, paving the way for more effective and individualized cancer treatments.
随着基因组学和蛋白质组学的突破性进展，精准医学正推动肿瘤外科学领域快速发展。本文探讨了分子数据整合如何重塑外科决策体系，并推动个体化治疗策略的实施。我们研究了新一代测序技术、蛋白质组学分析和分子影像学等新兴技术，这些技术为肿瘤生物学提供了关键见解，并指导外科干预实践。文章重点阐述了基因组与蛋白质组数据在术前规划及个体化切除策略制定中的应用。同时，我们将探讨这一快速发展领域当前面临的挑战与未来机遇，强调需要通过持续教育、跨学科协作和深入研究，充分释放精准医学在胸外科肿瘤学领域的潜力，从而为更有效、更个体化的癌症治疗开辟道路。
Advancing Thoracic Surgical Oncology in the Era of Precision Medicine
肿瘤(癌症)患者之家